Cite
HARVARD Citation
Sharma, P. et al. (2015). A Phase II, single-arm study of nivolumab in patients with metastatic or unresectable urothelial cancer who have progressed following treatment with a platinum agent. Journal for immunotherapy of cancer. 3 (2), p. 1. [Online].